ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
First patient in treatment in RhoVac's clinical phase IIb study in United Kingdom
January 08, 2021RhoVac AB announces, on January 7th, 2021, that the first patient in United Kingdom is enrolled in the company's clinical phase IIb study in prostate cancer, a study named RhoVac-002 ("BRaVac"). -
First patient in treatment in RhoVac's clinical phase IIb study in Sweden
September 18, 2020RhoVac AB ("RhoVac") announces today, on September 17 2020, that the first patient in Sweden is enrolled in the company's clinical phase IIb study in prostate cancer, a study named RhoVac-002 ("BRaVac").
Pharma Sources Insight January 2025
